Chakrabarti 2019 MiP2019

From Bioblast
Jump to: navigation, search
Lisa Chakrabarti
Levels of eicosanoids and cytokines reveal sex differences in cerebellar mitochondria in Parkinson’s disease and controls.

Link: MiP2019

Ingram TL, Ortori C, Shephard F, Barrett D, Chakrabarti L (2019)

Event: MiP2019

COST Action MitoEAGLE

At the request of the author, this abstract is not made available online.


Bioblast editor: Plangger M, Tindle-Solomon L


Labels: MiParea: Comparative MiP;environmental MiP, Gender  Pathology: Parkinson's 

Organism: Human  Tissue;cell: Nervous system 





Affiliations

Ingram TL(1), Ortori C(2), Shephard F(1), Barrett D(2), Chakrabarti L(1)
  1. SVMS
  2. School Pharmacy; Univ Nottingham, UK. - [email protected]

References

  1. Currais A (2015) Ageing and inflammation - A central role for mitochondria in brain health and disease. Ageing Res Rev 21:30–42.
  2. Bose A, Beal MF (2016) Mitochondrial dysfunction in Parkinson’s disease. J Neurochem 139:216-31.
  3. Savica R, Grossardt BR, Bower JH, Ahlskog JE, Rocca WA (2013) Risk factors for Parkinson’s disease may differ in men and women: an exploratory study. Horm Behav 63:308–14.